Quick Takeaways: Why It Matters? Zoetis’s launch of Lenivia (izenivetmab) in Canada and the EU introduces the first long-acting monoclonal antibody for canine osteoarthritis that binds a different NGF site than existing anti‑NGF therapies, offering up to three months of pain relief from a ...
Quick Takeaways: Why It Matters? Royal Canin’s Fresh Veterinary Diets give veterinarians a fresh, fully cooked therapeutic option in a fast-growing US therapeutic dog food market, aligning medical nutrition with owner demand for “fresh” feeding and strengthening Royal Canin’s position agai...
Quick Takeaways: Why It Matters? Tevra’s expansion of the Vetality First Aid Collection pushes more vet‑style OTC care into mainstream retail, making it easier for pet owners to treat common problems quickly at home and likely increasing self-care product sales and category growth at Walma...
Quick Takeaways: Why It Matters? The partnership gives PetMeds a new revenue channel and accelerates AutoShip adoption (recurring orders of eligible meds, preventatives, and prescription diets), while Rural King customers gain a convenient, trusted pharmacy option with sitewide 25% off and...
Quick Takeaways: Why It Matters? PetVivo’s new study shows that a single intra-articular Spryng injection with OsteoCushion technology can improve pain and function in dogs with stifle osteoarthritis and suspected cranial cruciate disease. While the authors call for larger studies with obj...
Quick Takeaways: Why It Matters? VARON’s new portable pet oxygen bundle and mask are designed to make home and emergency oxygen care more practical for pet owners, giving them a compact, mobile system that can be used with dogs, cats, birds, rabbits, and other small animals. The bundle pai...
Featured Article Cover Story Product Launch Partnership Research Updates Regulatory Updates Bond Vet and Small Door Veterinary Complete Merger Corporate transaction Bond Vet and Small Door Veterinary have completed their merger, creating one of the largest premium veterinary care networks ...
Quick Takeaways: Why It Matters? Akston could emerge as a serious competitor in the fast-growing anti‑NGF OA segment that Zoetis currently leads with its once‑monthly monoclonal. Because Akston’s Ambifect approach stimulates sustained endogenous anti‑NGF antibody responses, AKS‑548d remain...
Quick Takeaways: Why It Matters? Zoetis’ EC approval of Poulvac Procerta HVT-ND turns its single-dose, dual ND+Marek’s protection into a mainstream EU option, which should drive rapid adoption as producers shift from multi-vaccine schedules to a streamlined, in‑ovo or hatch-day protocol th...
Quick Takeaways: Why It Matters? By bringing real-time, cellular-level microscopic imaging into everyday veterinary workflows, without lab delays, InSpecta gives specialist, general, and mobile practices a new in‑house diagnostic capability that can speed decision-making and create billabl...
